US Broker Ratings

Canopy Growth Corporation (CGC) Stock Analysis: Exploring the 75% Potential Upside for Investors

Canopy Growth Corporation (NASDAQ: CGC), a key player in the cannabis industry, has been a focal point for investors seeking to capitalize on the burgeoning market for cannabis-related products. With..

DocuSign, Inc. (DOCU) Investor Outlook: Analyzing 38% Potential Upside in the Software Sector

As a leading player in the software application industry, DocuSign, Inc. (NASDAQ: DOCU) continues to capture the attention of investors with its innovative electronic signature solutions and growing reputation in..

Yalla Group Limited (YALA) Stock Analysis: Uncovering a Potential 44% Upside for Tech Investors

Yalla Group Limited (YALA), a burgeoning player in the technology sector, offers a unique investment opportunity for those interested in the thriving social networking and gaming industries within the Middle..

Domo, Inc. (DOMO) Stock Analysis: Exploring an 88.73% Upside Potential for Tech Investors

Domo, Inc. (NASDAQ: DOMO), a technology company headquartered in American Fork, Utah, presents a unique opportunity for investors with a potential upside of 88.73%, according to analyst ratings. Despite the..

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: Exploring a Potential 434.91% Upside

Investors looking for high-growth opportunities in the biotech sector might find Cartesian Therapeutics, Inc. (NASDAQ: RNAC) an intriguing prospect. With a remarkable potential upside of 434.91%, this clinical-stage biotechnology company..

Applovin Corporation (APP) Stock Analysis: Unveiling a 46.55% Potential Upside for Investors

Investors eyeing opportunities in the dynamic Communication Services sector may find Applovin Corporation (NASDAQ: APP) an intriguing prospect, particularly given its robust 46.55% potential upside based on current analyst ratings...

Aura Biosciences, Inc. (AURA) Stock Analysis: A Promising 207% Upside Potential in the Biotechnology Sector

Aura Biosciences, Inc. (NASDAQ: AURA) is capturing the attention of investors with its innovative approach in the biotechnology sector, aiming to revolutionize cancer treatment with precision therapies targeting solid tumors...

Quantum-Si Incorporated (QSI) Stock Analysis: Unraveling Its 183% Potential Upside

Quantum-Si Incorporated (NASDAQ: QSI), a pioneering force in the healthcare sector, particularly within the medical devices industry, is making waves with its innovative approach to proteomics. Headquartered in Branford, Connecticut,..

Alumis Inc. (ALMS) Stock Analysis: Examining the 52.64% Potential Upside in the Biotech Innovator

Alumis Inc. (ALMS), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising pipeline of treatments targeting autoimmune disorders. With a market capitalization of $3.17 billion,..

Phathom Pharmaceuticals (PHAT) Stock Analysis: Evaluating a Potential 114% Upside in the Biotech Sector

For investors eyeing opportunities in the biotechnology sector, Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) presents an intriguing proposition. With a current market capitalization of approximately $863.63 million, Phathom Pharmaceuticals is making..

Exxon Mobil (XOM) Stock Analysis: Navigating Opportunities Amidst a Potential Downside Risk

Exxon Mobil Corporation (NYSE: XOM), a titan in the energy sector, continues to command significant attention from investors as it navigates the complexities of the global oil and gas market...

Health Catalyst, Inc (HCAT): Investor Outlook Reveals Over 100% Potential Upside

For investors seeking opportunities in the healthcare sector, Health Catalyst, Inc. (NASDAQ: HCAT) presents a compelling case. Despite its current challenges, the company offers significant potential upside, with analyst ratings..

Sanara MedTech Inc. (SMTI) Stock Analysis: A Promising 92.93% Potential Upside in the Healthcare Sector

Sanara MedTech Inc. (NASDAQ: SMTI) is a noteworthy player in the healthcare sector, especially for investors eyeing opportunities in medical instruments and supplies. With a market capitalization of $166.74 million,..

SANUWAVE Health, Inc. (SNWV) Investor Outlook: Exploring a Potential 156% Upside in the Medical Device Sector

SANUWAVE Health, Inc. (NASDAQ: SNWV) stands at the forefront of innovation in the medical device industry, with a focus on regenerative medicine. The company, headquartered in Eden Prairie, Minnesota, is..

Spok Holdings, Inc. (SPOK) Stock Analysis: A Look at the 11.15% Dividend Yield and 24.67% Upside Potential

Spok Holdings, Inc. (NASDAQ: SPOK), a key player in the healthcare communication solutions sector, presents an intriguing opportunity for investors with its robust dividend yield and potential price upside. Headquartered..

Nyxoah SA (NYXH) Stock Analysis: Exploring a 251% Potential Upside in the Promising Sleep Apnea Market

Nyxoah SA (NASDAQ: NYXH), a Belgium-based healthcare innovator, is making waves in the medical instruments and supplies industry with its cutting-edge solutions for obstructive sleep apnea (OSA). Despite its current..

Mereo BioPharma Group plc (MREO): Investor Outlook with a 639.75% Potential Upside

Mereo BioPharma Group plc (NASDAQ: MREO) is a name that has recently caught the attention of investors due to its striking potential for growth. With a staggering potential upside of..

Absci Corporation (ABSI)

⚠️ No article content returned.

..

XOMA Royalty Corporation (XOMA) Stock Analysis: Exploring a Potential 140% Upside for Investors

XOMA Royalty Corporation (NASDAQ: XOMA), a prominent player in the biotechnology sector, is drawing significant attention from investors with its impressive potential upside of 140.40%. Specializing in biotech royalty aggregation,..

Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 65.92% Potential Upside in the Medical Devices Sector

Varex Imaging Corporation (NASDAQ: VREX) stands out in the healthcare sector, specifically within the medical devices industry, by offering a comprehensive range of X-ray imaging components for both medical and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds